Ignite Creation Date:
2024-05-06 @ 1:03 AM
Last Modification Date:
2024-10-26 @ 10:58 AM
Study NCT ID:
NCT01720381
Status:
COMPLETED
Last Update Posted:
2014-06-24
First Post:
2012-10-31
Brief Title:
OptiScanner Versus Standard Blood Glucose Monitoring
Sponsor:
Organization:
OptiScan Biomedical Corporation
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
One additional blood sample 4 mlwill be collected once a day separated into Draw an additional 40 mL from the subject into a syringe once per every 24 hour period The study site will indicate where and at what time the sample was taken This sample is placed into a sodium heparin tube labeled with the subject number and sampling time and centrifuged on a refrigerated centrifuge The gained plasma will be frozen at minus 70 degrees Celsius or less and may be used for potential analysis by the Sponsor should an analysis of outliers indicate the potential presence of an interferent
Enrollment Count:
98
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Control |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 19718 |
Who Masked List: